Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CISATRACURIUM BESYLATE How Supplied/Storage and Handling (cisatracurium besylate)

16 HOW SUPPLIED/STORAGE AND HANDLING

Cisatracurium besylate injection, USP is a clear solution supplied as follows:

Cisatracurium Besylate Injection, USP, 2 mg cisatracurium per mL, is supplied in the following:

StrengthNDC No.
(Unit of Sale)
NDC No.
(Each)
ContainerCarton Configuration
10 mg/5 mL0409-1098-020409-1098-125 mL Single-dose Vial10 Pack
20 mg/10 mL0409-1208-010409-1208-1110 mL Multiple-dose Vials10 Pack

NOTE: 10 mL Multiple-dose vials contain 0.9% w/v benzyl alcohol as a preservative [see Warnings and Precautions (5.2)].

Cisatracurium Besylate Injection, USP, 10 mg cisatracurium per mL is supplied in the following:

StrengthNDC No.
(Unit of Sale)
NDC No.
(Each)
ContainerCarton Configuration
200 mg/20 mL0409-1103-010409-1103-1120 mL Single-dose Vial10 Pack

Intended only for use in the ICU.

Discard unused portion of the 5 mL and 20 mL single-dose vials.

Storage

Cisatracurium Besylate Injection, USP should be refrigerated at 2° to 8°C (36° to 46°F) in the carton to preserve potency. Protect from light. DO NOT FREEZE. Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Cisatracurium Besylate Injection, USP within 21 days, even if re-refrigerated.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

*9AM-5PM ET Monday to Friday; excluding holidays.

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch